Heasquinazolinone, a New Heat-Shock Metabolite Produced by Thermotolerant Streptomyces sp. HR41
Chemical and Pharmaceutical Bulletin · 2025
DOI: 10.1248/cpb.c25-00519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Shun Saito und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan. Hauptthemen laut MEDLINE: Streptomyces, Quinazolinones, Antineoplastic Agents. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Informatics, Keio University, 3-14-1 Hiyoshi, Kohoku-ku, Yokohama 223-8522, Japan.
Zitieren
APA
Saito, S., Hagihara, R., & Arai, M. A. (2025). Heasquinazolinone, a New Heat-Shock Metabolite Produced by Thermotolerant Streptomyces sp. HR41. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00519
Vancouver
Saito S, Hagihara R, Arai MA. Heasquinazolinone, a New Heat-Shock Metabolite Produced by Thermotolerant Streptomyces sp. HR41. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00519
BibTeX
@article{Saito2025,
author = {Saito, Shun and Hagihara, Risa and Arai, Midori A},
title = {Heasquinazolinone, a New Heat-Shock Metabolite Produced by Thermotolerant Streptomyces sp. HR41},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/cpb.c25-00519}
}
EUVIMED